Cisplatin and Paclitaxel for Non–Small-Cell Lung Cancer: The European Experience
September 1st 1999Many physicians have questioned whether the additional survival benefit gained from the use of combination chemotherapy in non–small-cell lung cancer has been offset by chemotherapy-induced toxicity, particularly with